[{"address1": "2533 South Coast Highway 101", "address2": "Suite 210", "city": "Cardiff", "state": "CA", "zip": "92007", "country": "United States", "phone": "858 400 8470", "website": "https://www.viracta.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. The company's lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. It's Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. The company's product pipeline also includes vecabrutinib, a clinical-stage product candidate; and VRx-510, a preclinical product candidate. The company is headquartered in Cardiff, California.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig R. Jalbert CIRA", "age": 62, "title": "CEO, President, CFO, Treasurer, Corporate Secretary & Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.00978, "open": 0.0096, "dayLow": 0.008, "dayHigh": 0.0096, "regularMarketPreviousClose": 0.00978, "regularMarketOpen": 0.0096, "regularMarketDayLow": 0.008, "regularMarketDayHigh": 0.0096, "payoutRatio": 0.0, "beta": 0.276, "forwardPE": -0.016032787, "volume": 379813, "regularMarketVolume": 379813, "averageVolume": 0, "averageVolume10days": 0, "averageDailyVolume10Day": 0, "bid": 0.0081, "ask": 0.0109, "bidSize": 95100, "askSize": 20644, "marketCap": 388699, "fiftyTwoWeekLow": 0.008, "fiftyTwoWeekHigh": 0.2972, "allTimeHigh": 18.24, "allTimeLow": 0.008, "fiftyDayAverage": 0.00978, "twoHundredDayAverage": 0.02755105, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3832301, "profitMargins": 0.0, "floatShares": 31258036, "sharesOutstanding": 39744200, "sharesShort": 246035, "sharesShortPriorMonth": 2998341, "sharesShortPreviousMonthDate": 1734048000, "dateShortInterest": 1736899200, "sharesPercentSharesOut": 0.0062, "heldPercentInsiders": 0.02987, "heldPercentInstitutions": 0.21180001, "shortRatio": 0.11, "shortPercentOfFloat": 0.007900001, "impliedSharesOutstanding": 39744300, "bookValue": -0.166, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -43289000, "trailingEps": -1.1, "forwardEps": -0.61, "enterpriseToEbitda": 0.082, "52WeekChange": -0.95925, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 0.00978, "recommendationKey": "none", "totalCash": 21132000, "totalCashPerShare": 0.532, "ebitda": -46773000, "totalDebt": 16911000, "quickRatio": 0.74, "currentRatio": 0.763, "returnOnAssets": -0.66763, "returnOnEquity": -3.70134, "freeCashflow": -23356250, "operatingCashflow": -34796000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "VIRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Viracta Therapeutics, Inc.", "longName": "Viracta Therapeutics, Inc.", "regularMarketChange": 0.0, "regularMarketDayRange": "0.008 - 0.0096", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 0, "fiftyTwoWeekLowChange": 0.0017799996, "fiftyTwoWeekLowChangePercent": 0.22249994, "fiftyTwoWeekRange": "0.008 - 0.2972", "fiftyTwoWeekHighChange": -0.28742, "fiftyTwoWeekHighChangePercent": -0.9670929, "fiftyTwoWeekChangePercent": -95.924995, "dividendDate": 1599091200, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755547200, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1614263400000, "corporateActions": [], "regularMarketTime": 1760572800, "exchange": "PNK", "messageBoardId": "finmb_38720301", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.1, "epsForward": -0.61, "fiftyDayAverageChange": 0.0, "fiftyDayAverageChangePercent": 0.0, "twoHundredDayAverageChange": -0.01777105, "twoHundredDayAverageChangePercent": -0.64502263, "priceToBook": -0.058915664, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.00978, "marketState": "CLOSED", "displayName": "Viracta Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]